Beets, along with carrots, onions, potatoes, turnips, parsnips, radishes, horseradish, jicama, ginger, and garlic are all considered roots. We know them as root vegetables or herbs since they grow underground and, in doing so, absorb huge amounts of   (Read More)

When Sally was a single parent raising four boys, working 11 hours a day and taking care of her elderly patients, nothing could get her down. Years later, it would be this can-do attitude that would help her through the diagnosis of cervical cancer.   (Read More)

This month is National Colon Cancer Awareness Month. According to the American Cancer Society (ACS), colon cancers (of the colon and rectum) are the country’s “third leading cause of cancer death among men and women.” Although   (Read More)

OHC encourages adult cancer patients who are undergoing or who have completed their cancer treatment to participate in the LIVESTRONG® program brought to you by the Blue Ash YMCA. The program will benefit cancer patients in a transitional   (Read More)

OHC medical oncologist Dr. David Waterhouse, Chair of Clinical Research, was recognized as the winner in the Innovator category at the Cincinnati Business Courier 2016 Health Care Heroes Award Banquet. In front of over 400 attendees, Dr. Waterhouse   (Read More)

Lung cancer is the second most common cancer in both men and women in the United States, claiming an estimated 158,040 Americans in 2015 according to the American Lung Association. Cigarette smoking causes most lung cancers, and high levels of   (Read More)

It is with mixed feelings that OHC announces the retirement of our beloved and much appreciated Dr. John A. Bismayer, M.D. His last day is Mon., Feb. 8, 2016. His medical career has spanned close to four decades and his time with OHC has been   (Read More)

Today, the OHC team and our patients are uniting with supporters from around the world in the fight against cancer as part of the Union for International Cancer Control’s (UICC) celebration of World Cancer Day. World Cancer Day rallies as many   (Read More)

There are many misperceptions about clinical trials and the benefits they provide individuals battling cancer. As the leading provider of clinical trials in the tri-state area, OHC continues to invest resources in providing and educating the   (Read More)

As you might recall, last week we introduced you to the Help section of the OHC website. In particular, we detailed the information and resources that are just one click away from making your first day at OHC a smooth one. Today,   (Read More)

OHC completely rebuilt its website two years ago in order to provide you with helpful information and guidance throughout your cancer care treatment. We want to encourage you to explore one area of the site in particular — the HELP section —   (Read More)

According to the National Institutes of Health (NIH), cancer care costs are projected to reach at least $158 billion in 2020. To reduce costs, the health care industry must take steps to eliminate unnecessary and redundant tests and treatments, while   (Read More)

Thirty-five abstracts authored by members of the Sarah Cannon Blood Cancer Network were presented at the recent American Society of Hematology (ASH) Meeting and Exposition. OHC expert hematologists Dr. James H. Essell and Dr. Ed Faber were co-authors   (Read More)

OHC is offering two new clinical trials. To view our entire research clinical trial menu, please click here. 1) Lynch Syndrome Trial This is an investigational trial that runs analyses on patients’ blood, saliva, and tumor tissue to determine if   (Read More)

We have seen significant progress in how cancer is treated this last year. Individualized and personalized therapy has revolutionized the treatment plan for many cancer types. Nivolumab, a new immunotherapy drug used to treat advanced non-squamous,   (Read More)